EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Severe bilateral chorioretinopathy associated with ipilimumab in a patient with metastatic melanoma

Víctor Manuel Asensio-Sánchez

GMS Ophthalmology Cases · 25.11.2025 · 15 (Doc14) · Doc14-Doc14

DOI: 10.3205/oc000262 ↗

Kurz gefasst

Fallbericht in der Zeitschrift GMS Ophthalmology Cases, erschienen am 25.11.2025. Verfasst von Víctor Manuel Asensio-Sánchez. Beteiligte Einrichtung: Ophthalmology Department, University Clinical Hospital, Valladolid, Spain. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To report a rare case of severe bilateral chorioretinopathy associated with ipilimumab in a patient with metastatic melanoma, highlighting the ocular toxicities that may arise from immune checkpoint inhibitors.

Methods

A 38-year-old woman receiving ipilimumab (3 mg/kg every 3 weeks) for metastatic melanoma presented with painless bilateral vision loss following her third dose. Clinical assessment included visual acuity testing, fundus examination, fluorescein angiography (FA), and optical coherence tomography (OCT) to evaluate retinal changes. The ipilimumab treatment was discontinued, but the patient refused corticosteroid therapy.

Results

Fundus examination and OCT revealed bilateral serous retinal detachments with retinal pigment epithelium (RPE) detachment. FA demonstrated multiple pinpoint leakage areas at the RPE level. Over a three-month follow-up period, visual acuity further declined, resulting in total vision loss in one eye and persistent bilateral serous detachments despite cessation of ipilimumab.

Conclusions

This case highlights the potential for severe, irreversible vision loss due to ipilimumab-associated chorioretinopathy, underscoring the importance of early ophthalmological assessment and continuous monitoring in patients undergoing immune checkpoint inhibitor therapy. Early recognition and intervention are critical, especially when systemic corticosteroids are not administered.

Schlagwörter

Stichwörter der Autor:innen

central serous chorioretinopathyimmune checkpoint inhibitorsipilimumabmetastatic melanomaocular toxicityretinal pigment epithelium detachmentvision loss

Autor:innen und Institutionen

  • Ophthalmology Department, University Clinical Hospital, Valladolid, Spain.

Zitieren

APA

Asensio-Sánchez, V. M. (2025). Severe bilateral chorioretinopathy associated with ipilimumab in a patient with metastatic melanoma. GMS Ophthalmology Cases, 15(Doc14), Doc14-Doc14. https://doi.org/10.3205/oc000262

Vancouver

Asensio-Sánchez VM. Severe bilateral chorioretinopathy associated with ipilimumab in a patient with metastatic melanoma. GMS Ophthalmology Cases. 2025;15(Doc14):Doc14-Doc14. doi:10.3205/oc000262

BibTeX
@article{AsensioSnchez2025,
  author = {Asensio-Sánchez, Víctor Manuel},
  title = {Severe bilateral chorioretinopathy associated with ipilimumab in a patient with metastatic melanoma},
  journal = {GMS Ophthalmology Cases},
  year = {2025},
  volume = {15},
  number = {Doc14},
  pages = {Doc14--Doc14},
  doi = {10.3205/oc000262}
}
Kostenlos starten →